IL13 and neoplasm: Similarly, Ovatodiolide inhibits the expression of YAP-regulated M2 tumor-associated macrophage polarization factors, such as IL-4 and IL-13, altering the tumor microenvironment and thereby regulating the progression of CRC (127).